History
  • No items yet
midpage
Macaluso v. Bristol-Myers Squibb
1:17-cv-01460
| S.D.N.Y. | Oct 18, 2016
|
Check Treatment
|
Docket
Case Information

*1 Case 1:17-cv-01460-DLC Document 26 Filed 10/18/16 Page 1 of 2 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA KAREN MACALUSO,

INDIVIDUALLY AND AS THE

PERSONAL REPRESENTATIVE OF

THE ESTATE OF JOSEPHINE GALIANO CIVIL ACTION

VERSUS No. 16-3673

BRISTOL-MYERS SQUIBB ET AL. SECTION I

ORDER AND REASONS

Before the Court is defendants’ motion [1] to dismiss and for a more definite statement. The Court recently resolved a substantively identical motion in another

case pending before it, one involving the same defendants as this case and all of the

same lawyers. See Huffman v. Bristol-Myers Squibb et al. , Civil Action No. 16-3714,

R. Doc. No. 27. In fact, the only difference worth noting between this case and

Huffman in terms of the legal issues raised by defendants’ motion is that in this case

the plaintiff is suing individually and in a representative capacity on behalf of

Josephine Galiano, who allegedly died as the result of defendants’ product. Compl.

¶¶ 4, 13.

It follows that the result in Huffman should also govern here. Accordingly, for the same reasons provided in this Court’s order and reasons in the Huffman case, [2]

*2 Case 1:17-cv-01460-DLC Document 26 Filed 10/18/16 Page 2 of 2 IT IS ORDERED that defendants’ motion to dismiss is GRANTED IN PART and DENIED IN PART as set forth herein . Plaintiff has leave to file an amended

complaint addressing the present infirmities with the failure to warn claim no later

than October 26, 2016 . Should defendants still contend that any amended

complaint does not plead causation on the failure to warn claim, defendants may file

a motion to dismiss the claim on such grounds no later than November 4, 2016 .

Should defendants do so, plaintiff shall respond no later than November 14, 2016 ,

at which point the Court will take the motion under submission.

IT IS ORDERED that defendants’ motion for a more definite statement is GRANTED. No later than October 26, 2016 , plaintiff shall file an amended

complaint specifying (1) when the decedent was injured by Eliquis, and (2) when the

decedent became aware of her injuries. Should defendants contend that dismissal on

prescription grounds is appropriate based on the pleadings, defendants shall so move

no later than November 4, 2016 . [3] Should defendants do so, plaintiff shall respond

no later than November 14, 2016 , at which point the Court will take the motion

under submission.

New Orleans, Louisiana, October 18, 2016. _______________________________________ LANCE M. AFRICK UNITED STATES DISTRICT JUDGE

[1] R. Doc. No. 14.

[2] Huffman v. Bristol-Myers Squibb et al. , Civil Action No. 16-3714, R. Doc. No. 27.

[3] To be clear, failure to so move would not waive the ability to timely move for summary judgment on the issue provided that any such defense is raised in the answer. 2

Case Details

Case Name: Macaluso v. Bristol-Myers Squibb
Court Name: District Court, S.D. New York
Date Published: Oct 18, 2016
Docket Number: 1:17-cv-01460
Court Abbreviation: S.D.N.Y.
AI-generated responses must be verified and are not legal advice.
Your Notebook is empty. To add cases, bookmark them from your search, or select Add Cases to extract citations from a PDF or a block of text.